Clinical Microbiology Market is Expected to Reach $12,411.36 Million in 2019 - New Research Report by MarketsandMarkets
(PRWEB) January 31, 2015 -- In this report the global clinical microbiology market is segmented on the basis of products and applications. On the basis of products, the clinical microbiology market is segmented into consumables and instruments. Each of these market segments is further divided into multiple product segments and sub-segments.
For Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/microbiology-testing-market-219135367.html
The clinical microbiology consumables is further bifurcated into kits and reagents, whereas the clinical microbiology instruments market is segmented into automated microbiology instruments, laboratory instruments and microbiology analysers. The laboratory instruments are further categorized into anaerobic gas systems, automated gram stainer, automated Petri dish fillers, autoclave sterilizers, bacterial colony counters, incubators, microbial air samplers and other laboratory instruments; whereas the microbiology analysers are further categorized into mass spectrometers, microscopes and molecular diagnostics instruments.
Do Report Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=219135367
Clinical microbiology has applications in a large number of infectious diseases. On the basis of applications, the report is segmented into bloodstream infections, gastrointestinal diseases, periodontal diseases, respiratory diseases, sexually transmitted diseases, urinary tract infections and other diseases. The geographic segments included in this report are Asia, Europe, North America and Rest of the World.
The large disease burden of infectious diseases is the key growth driver for this market. The outbreak of new diseases has further aided the growth of this market. The growing trend of laboratory automation and the increase in access to medical insurance in the U.S. market will aid the growth of this market. Moreover, increased healthcare expenditure will drive the growth of this market.
In this report, a combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates. Secondary information was used to identify the overall revenue, geographic reach and product portfolios of the market players. Estimates of their clinical microbiology segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates.
Ask for Report Customization @ http://www.marketsandmarkets.com/requestCustomization.asp?id=219135367
The report provides qualitative insights about the key market shares, growth rates and market drivers for all important sub-segments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders. These company profiles include financial performances, product portfolios and market developments for each company. Moreover, the report provides a competitive landscape of the clinical microbiology market. The competitive landscape covers the growth strategies adopted by industry players over the last three years such as mergers and acquisitions, agreements and partnerships and new product launches.
Major players in this market include Abbott Laboratories, Inc. (U.S.), Alere, Inc. (U.S.), bioMérieux SA (France), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.) Cepheid (U.S.), Danaher Corporation (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland) and Siemens AG (Germany).
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
e-mail: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology
Mr.Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article